A randomized trial of atropine vs patching for treatment of moderate amblyopia: Follow-up at age 10 years

Archives of Ophthalmology

Volumn 126, Issue 8, 2008, Pages 1039-1044

  Repka, Michael X ^a,i   Kraker, Raymond T ^j   Beck, Roy W ^j   Holmes, Jonathan M ^b   Cotter, Susan A ^c   Birch, Eileen E ^j   Astle, William F ^d   Chandler, Danielle L ^j   Felius, Joost ^e   Arnold, Robert W ^f   Tien, D Robbins ^g   Glaser, Stephen R ^h  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

^c SOUTHERN CALIFORNIA COLLEGE OF OPTOMETRY   (United States)

^d ALBERTA CHILDREN'S HOSPITAL   (Canada)

^e Pediatric Ophthalmology PA   (United States)

^f Ophthalmic Associates   (United States)

^g Pediatric Ophthalmology and Strabismus Associates   (United States)

^h Pediatric Ophthalmology of Erie   (United States)

ⁱ JAEB CENTER FOR HEALTH RESEARCH   (United States)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE;

AMBLYOPIA; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ACUITY;

AMBLYOPIA; ATROPINE; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYDRIATICS; REFRACTION, OCULAR; SENSORY DEPRIVATION; TREATMENT OUTCOME; VISION, BINOCULAR; VISUAL ACUITY;

EID: 49449104068     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.8.1039     Document Type: Article

References (22)

1. National Eye Institute Office of Biometry and Epidemiology. Report on the National Eye Institute's Visual Acuity Impairment Survey Pilot Study. Washington, DC: Dept of Health and Human Services; 1984.
2. Attebo K, Mitchell P, Cumming R, et al. Prevalence and causes of amblyopia in an adult population. Ophthalmology. 1998;105(1):154-159.
3. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120(3):268-278.
4. Repka MX, Cotter SA, Beck RW, et al; Pediatric Eye Disease Investigator Group. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology. 2004;111(11):2076-2085.
5. Wallace DK; Pediatric Eye Disease Investigator Group. A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology. 2006;113(6):904-912.
6. Gregersen E, Rindziunski E. "Conventional" occlusion in the treatment of squint amblyopia: a 10-year followup. Acta Ophthalmol (Copenh). 1965;43(4):462-474.
7. Fletcher MC, Silverman SJ, Boyd J, Callaway M. Biostatistical studies: comparison of the management of suppression amblyopia by conventional patching, intensive hospital pleoptics, and intermittent office pleoptics. Am Orthopt J. 1969;19:40-47.
8. Rutstein RP, Fuhr PS. Efficacy and stability of amblyopia therapy. Optom Vis Sci. 1992;69(10):747-754.
9. Levartovsky S, Oliver M, Gottesman N, Shimshoni M. Factors affecting long term results of successfully treated amblyopia: initial visual acuity and type of amblyopia. Br J Ophthalmol. 1995;79(3):225-228.
10. Leiba H, Shimshoni M, Oliver M, Gottesmann N, Levartovsky S. Long-term follow-up of occlusion therapy in amblyopia. Ophthalmology. 2001;108(9):1552-1555.
11. Sparrow JC, Flynn JT. Amblyopia: a long-term follow-up. J Pediatr Ophthalmol. 1977;14(6):333-336.
12. Holmes JM, Beck RW, Kraker RT, et al; Pediatric Eye Disease Investigator Group. Risk of amblyopia recurrence after cessation of treatment. J AAPOS. 2004;8(5):420-428.
13. Holmes JM, Beck RW, Kraker RT, et al; Pediatric Eye Disease Investigator Group. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2005;123(2):149-157.
14. Beck RW, Moke PS, Turpin AH, et al. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol. 2003;135(2):194-205.
15. Holmes JM, Beck RW, Repka MX, et al. The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol. 2001;119(9):1345-1353.
16. Simons K, Stein L, Sener EC, Vitale S, Guyton DL. Full-time atropine, intermittent atropine, and optical penalization and binocular outcome in treatment of strabismic amblyopia. Ophthalmology. 1997;104(12):2143-2155.
17. Kushner BJ. Concern about the Pediatric Eye Disease Investigator Group 2-year follow-up study. Arch Ophthalmol. 2005;123(11):1615-1616.
18. Flynn JT, Woodruff G, Thompson JR, et al. The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled data sets. Trans Am Ophthalmol Soc. 1999;97:373-395.
19. Bhola R, Keech RV, Kutschke P, Pfeifer W, Scott WE. Recurrence of amblyopia after occlusion therapy. Ophthalmology. 2006;113(11):2097-2100.
20. Bowman RJC, Williamson TH, Andrews RGL, Aitchison TC, Dutton GN. An inner city preschool visual screening programme: long-term visual results. Br J Ophthalmol. 1998;82(5):543-548.
21. Scott WE, Dickey CF. Stability of visual acuity in amblyopic patients after visual maturity. Graefes Arch Clin Exp Ophthalmol. 1988;226(2):154-157.
22. Kutschke PJ, Scott WE, Keech RV. Anisometropic amblyopia. Ophthalmology. 1991;98(2):258-262.